Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000232442 | SCV000284708 | benign | Tuberous sclerosis 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000245356 | SCV000303865 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000245356 | SCV000344517 | likely benign | not specified | 2016-09-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000232442 | SCV000478261 | likely benign | Tuberous sclerosis 1 | 2018-03-26 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000403188 | SCV000478262 | likely benign | Isolated focal cortical dysplasia type II | 2018-03-26 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Ambry Genetics | RCV000573437 | SCV000675349 | benign | Hereditary cancer-predisposing syndrome | 2015-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001682935 | SCV001905367 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000232442 | SCV002040513 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000573437 | SCV002528899 | benign | Hereditary cancer-predisposing syndrome | 2021-04-23 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002494623 | SCV002807770 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001682935 | SCV004010886 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | TSC1: BP4, BP7, BS1 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001682935 | SCV004221392 | benign | not provided | 2015-05-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003998774 | SCV004840554 | benign | Tuberous sclerosis syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing |